Viridian Therapeutics, Inc. · NASDAQ:VRDN

Paradigm Biocapital Advisors LP reported a 5.10% stake in Viridian Therapeutics, Inc. (Schedule 13G)

Event Jun 18, 2026 · Filed Jun 26, 2026

Paradigm Biocapital Advisors LP reported a 5.10% stake in Viridian Therapeutics, Inc., 5,633,788 shares, as a passive investor on Jun 18, 2026. Filed Jun 26, 2026 (Schedule 13G).

Stake
5.10%
Shares
5,633,788
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP5.10%5,633,788
Paradigm BioCapital Advisors GP LLC5.10%5,633,788
Senai Asefaw, M.D.5.10%5,633,788
Paradigm BioCapital International Fund Ltd.4.50%4,942,532

Source

View original at SEC

Related